Guardian Pharmacy Services vs Healthequity
Guardian Pharmacy Services and Healthequity are similar in size: $1.45bn and $1.31bn of revenue in their latest fiscal years. Guardian Pharmacy Services grew faster (17.9% against 9.5%). Healthequity kept more of each dollar of sales as profit: a net margin of 16.4% against 3.4%. Guardian Pharmacy Services carries less debt relative to equity (0.0% against 45.4%).
| Latest fiscal year | Guardian Pharmacy ServicesGRDN, 2025 | HealthequityHQY, 2026 |
|---|---|---|
| Revenue | $1.45bn | $1.31bn |
| Revenue growth | 17.9% | 9.5% |
| Net income | $49.2m | $215m |
| Operating margin | 5.0% | 24.6% |
| Net margin | 3.4% | 16.4% |
| Return on equity | 26.8% | 10.2% |
| Free cash flow | $86.8m | $455m |
| Cash | $65.6m | $319m |
| Total debt | $0 | $957m |
| Debt to equity | 0.0% | 45.4% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | $299m |
| Employees | — | 2,814 |
| Market value | $2.53bn | $8.60bn |
| Price vs our value range | — | Within our value range |
| Moat score | — | 64 (Moderate) |
| Insider trades, 12 months | 1 buys, 10 sales | 2 buys, 13 sales |